Spots Global Cancer Trial Database for oral vinorelbine
Every month we try and update this database with for oral vinorelbine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression | NCT02919462 | Carcinoma, Non-... Secondary Advanced Stage ... High Thymidylat... | Oral vinorelbin... Cisplatin Maintenance wit... Pemetrexed Cisplatin Maintenance wit... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial | NCT02319577 | Non Small Cell ... | oral vinorelbin... Gefitinib | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria | NCT02619929 | Non-Small-Cell ... Breast Cancer | Vinorelbine ora... | 18 Years - | Pierre Fabre Pharma GmbH | |
| Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca | NCT02144194 | Breast Cancer | Vinorelbine-Doc... Vinorelbine | 18 Years - | Cancer Research Group - Collaborative Group, Beirut, Lebanon. | |
| Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression | NCT02919462 | Carcinoma, Non-... Secondary Advanced Stage ... High Thymidylat... | Oral vinorelbin... Cisplatin Maintenance wit... Pemetrexed Cisplatin Maintenance wit... | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) | NCT04296162 | Breast Cancer | Vinorelbine Capecitabine Trastuzumab | 18 Years - 70 Years | Fudan University | |
| Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma | NCT02197637 | Low-Grade Gliom... | ORAL VINORELBIN... | 6 Years - 17 Years | Centre Oscar Lambret | |
| Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA) | NCT02802748 | Breast Cancer | Oral Vinorelbin... Letrozole | 18 Years - | SOLTI Breast Cancer Research Group | |
| Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer | NCT02768415 | Breast Cancer | Apatinib Oral Vinorelbin... | 18 Years - 75 Years | ChineseAMS | |
| Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID) | NCT04296162 | Breast Cancer | Vinorelbine Capecitabine Trastuzumab | 18 Years - 70 Years | Fudan University | |
| Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria | NCT02619929 | Non-Small-Cell ... Breast Cancer | Vinorelbine ora... | 18 Years - | Pierre Fabre Pharma GmbH |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
